| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,052 |
11,908 |
$655K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,969 |
16,015 |
$588K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,097 |
5,895 |
$503K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,388 |
6,255 |
$456K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,242 |
3,981 |
$340K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,102 |
4,020 |
$289K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,563 |
13,978 |
$62K |
| 97802 |
|
15,700 |
15,115 |
$55K |
| 99381 |
|
699 |
677 |
$46K |
| 99383 |
|
563 |
481 |
$39K |
| 99382 |
|
220 |
210 |
$19K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
278 |
267 |
$18K |
| 99384 |
|
185 |
177 |
$14K |
| 99188 |
|
4,586 |
4,377 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,021 |
993 |
$9K |
| 81002 |
|
13,308 |
12,960 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,478 |
1,194 |
$6K |
| 85018 |
|
15,627 |
15,231 |
$6K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
126 |
103 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
300 |
298 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
764 |
734 |
$2K |
| 83655 |
|
1,604 |
1,536 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
13 |
$1K |
| 99173 |
|
14,120 |
13,021 |
$309.82 |
| 90661 |
|
310 |
310 |
$276.96 |
| 90686 |
|
2,918 |
2,847 |
$163.51 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
484 |
465 |
$153.50 |
| 87807 |
|
135 |
132 |
$123.98 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
74 |
73 |
$120.00 |
| 94760 |
|
434 |
412 |
$117.15 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
37 |
37 |
$79.61 |
| 90651 |
|
2,133 |
1,984 |
$60.00 |
| 99401 |
|
4,635 |
4,386 |
$50.00 |
| 99051 |
|
635 |
622 |
$37.85 |
| 90700 |
|
537 |
490 |
$30.01 |
| 90633 |
|
1,822 |
1,759 |
$10.03 |
| 96127 |
|
6,551 |
5,993 |
$10.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
663 |
627 |
$1.37 |
| 90715 |
|
781 |
758 |
$0.86 |
| 90670 |
|
2,146 |
2,041 |
$0.83 |
| 90660 |
|
56 |
55 |
$0.42 |
| 90710 |
|
1,586 |
1,551 |
$0.09 |
| 90696 |
|
743 |
727 |
$0.04 |
| 90648 |
|
1,176 |
1,116 |
$0.01 |
| 90671 |
|
338 |
330 |
$0.01 |
| 90656 |
|
52 |
52 |
$0.01 |
| 90734 |
|
877 |
845 |
$0.00 |
| 90681 |
|
191 |
178 |
$0.00 |
| 87400 |
|
56 |
27 |
$0.00 |
| 90707 |
|
33 |
33 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
47 |
45 |
$0.00 |
| 90723 |
|
342 |
320 |
$0.00 |
| 90697 |
|
292 |
212 |
$0.00 |
| 90698 |
|
886 |
864 |
$0.00 |
| 99000 |
|
1,078 |
1,023 |
$0.00 |
| 90677 |
|
258 |
179 |
$0.00 |
| 90744 |
|
223 |
218 |
$0.00 |
| 90680 |
|
1,561 |
1,432 |
$0.00 |
| 90619 |
|
581 |
577 |
$0.00 |
| 86769 |
|
41 |
29 |
$0.00 |